# Corporation Tax Act 2009, Paragraph 112


(1) In relation to expenditure incurred before 1 August 2008, Part 13 has effect with the following modifications.
(2) In Chapter 2 (relief for SMEs: cost of R&D incurred by SME)—
(a) in section 1044(8), for “75%” substitute “ 50% ”,
(b) in section 1045(7), for “175%” substitute “ 150% ”,
(c) in section 1055(2)(b), for “175%” substitute “ 150% ”, and
(d) in section 1058(1)(a), for “14%” substitute “ 16% ”.
(3) In Chapter 7 (relief for SMEs and large companies: vaccine research etc)—
(a) in section 1089(2), for “40%” substitute “ 50% ”,
(b) in section 1090(2), for “40%” substitute “ 50% ”,
(c) in section 1091—
(i) in subsection (3), for “40%” substitute “ 50% ”, and
(ii) in subsection (4), for “140%” substitute “ 150% ”,
(d) in section 1092(8)—
(i) in paragraph (a), for “40%” substitute “ 50% ”, and
(ii) in paragraph (b), for “140%” substitute “ 150% ”, and
(e) in section 1104(5), for “140%” substitute “ 150% ”.

---
Source: https://www.legislation.gov.uk/ukpga/2009/4/schedule/2/paragraph/112 (the official version)
Page: https://openlegislation.uk/corporation-tax-act-2009/schedule-2/paragraph-112
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.